News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Alfredo Rivas-Delgado: Review on treating high-risk MCL patients by Anita Kumar
Photo from Alfredo Rivas-Delgado/X
Apr 29, 2024, 00:54

Alfredo Rivas-Delgado: Review on treating high-risk MCL patients by Anita Kumar

Alfredo Rivas-Delgado, Research Fellow at Memorial Sloan Kettering Cancer, posted on X/Twitter:

“A comprehensive review on treating high-risk MCL patients by Anita Kumar

– High Ki67, TP53mut, blastoid morphology, POD24
– Targeted therapy including BTKi + BCL2inh + antiCD20
– Promising data with CAR-T and BsAbs
– Refer early to tertiary centers.“

Source: Alfredo Rivas-Delgado/X

Alfredo Rivas-Delgado Anita Kumar blastoid morphology cancer CAR-T and BsAbs High Ki67 high-risk MCL patients OncoDaily Oncology POD24 targeted therapy tertiary centers TP53mut
Special Coverage
Blog
Aug 31, 2024, 18:36
Asaf Maoz: Looking Back, Facing Forward is coming up September 14th
Insight
Aug 31, 2024, 18:34
Erman Akkus: First line treatment of metastatic Colorectal Cancer in older patients
Blog
Aug 31, 2024, 18:32
Matthias Ocker: Novel small molecule MCL-1 inhibitor in vivo clearance and robust efficacy in solid and hematological tumor models
Insight
Aug 31, 2024, 18:28
Sharon Baumel-Alterzon: I will be opening my own lab in Oct 2024 at City of Hope
Blog
Aug 31, 2024, 18:27
Julie McCrossin: Sze Yarn Sin’s presentation on proton therapy
Insight
Aug 31, 2024, 18:25
Maqbul Jamil: Do Australians live longer?
Blog
Aug 31, 2024, 18:21
Funding available for SIOP Member Project Ideas
Blog
Aug 31, 2024, 18:14
Raffaele Giusti: Time Toxicity of Cancer Treatment - Discussion at ESMO 2024
Drugs
Aug 31, 2024, 17:49
Mark Lewis: From the first day of fellowship I was taught to “respect oxaliplatin"
Insight
Aug 31, 2024, 17:42
Miriam Mutebi: Opportunity to coordinate Africa's biggest cancer congress and be a part of impactful change
Blog
Aug 31, 2024, 17:34
Bente Mikkelsen: A groundbreaking milestone achieved for diabetes in the WHO African Region!
Blog
Aug 31, 2024, 17:33
Sylvester Comprehensive Cancer Center's second annual APP Oncology Symposium